Pharmacokinetic-based prophylaxis of replacement factor VIII (FVIII) items has been prompted lately, but the romantic relationship between exposure (factor VIII activity) and response (bleeding frequency) remains unclear

Pharmacokinetic-based prophylaxis of replacement factor VIII (FVIII) items has been prompted lately, but the romantic relationship between exposure (factor VIII activity) and response (bleeding frequency) remains unclear. in the 12-month pre-study period raising the blood loss hazard. Nevertheless, unexplained inter-patient…